SP

Sadassivam Pisupati Venkataraman

Active Director Director DIN 01274463
DIN 01274463 First appointment Aug 2008 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Sadassivam Pisupati Venkataraman

Data last updated:

Sadassivam Pisupati Venkataraman is a Director at Prisam Pharmaceuticals Private Limited (since 2008). The company operates in Pharma.

DIN 01274463
Primary Designation Director
Industry Pharma
First Appointment 18 Aug 2008
Oldest Company Age 29 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Aug 20081997Active

Board colleagues of Sadassivam Pisupati Venkataraman

Directorship timeline

Open interactive timeline →
Prisam Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sadassivam Pisupati Venkataraman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sadassivam Pisupati Venkataraman

Sadassivam Pisupati Venkataraman currently holds 1 directorship: Prisam Pharmaceuticals Private Limited (Director, since 18 Aug 2008).

Sadassivam Pisupati Venkataraman was first appointed on 18 Aug 2008 as Director at Prisam Pharmaceuticals Private Limited.

The current boards of Sadassivam Pisupati Venkataraman's companies include Dinakar Karaikal Parthasarathy (Prisam Pharmaceuticals Private Limited), Gouthamchand Arunkumar (Prisam Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available